ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OPTI Optibiotix Health Plc

17.75
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 17.75 17.50 18.00 17.75 17.75 17.75 58,159 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.25 16.19M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 17.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.19 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.25.

Optibiotix Health Share Discussion Threads

Showing 19826 to 19849 of 147550 messages
Chat Pages: Latest  802  801  800  799  798  797  796  795  794  793  792  791  Older
DateSubjectAuthorDiscuss
19/1/2017
22:39
Finncap have already fired a shot across the bows of the MMs for a vicious mark down for someone needing stock before, so hopefully if a sizeable lump is needed again they may be able to facilitate. Evans 850k was not just dumped on the market, it appear to have been worked in for someone. Hopefully, the volatile days are over.
elrico
19/1/2017
22:15
was your sceptism ok? ;-)
fozdad
19/1/2017
22:14
Couple of typos there:

"To suggest otherwise is to propose...."

And current not cittern positive indicators!

owenmo
19/1/2017
22:13
You'll win even fewer posting twice !

Another positive day for the good ship Optibiotix. Building blocks being put in place. Hope those who were reviewing their positions by the end of the year didn't sell.

whl2
19/1/2017
22:09
I'll win few friends in proposing that this 200 DMA stuff is a crystal clear retrospective - changing daily on the back of market movement - only not directing it! Share-price movement creates the chart; the chart doesn't generate where the line may be headed. To suggest otherwise I'd to propose that tomorrow's buyers (if such there be) come on board by dint of where we're at on the moving average. Is it not more realistic that investors will buy-in on the back of cittern positive indicators - in turn bringing the moving average with them. Clearly I'm a chart sceptic but will own up to ignorance to go hand-in-hand with my sceptism.
owenmo
19/1/2017
22:08
I'll win few friends in proposing that this 200 DMA stuff is a crystal clear retrospective - changing daily on the back of market movement - only not directing it! Share-price movement creates the chart; the chart doesn't generate where the line may be headed. To suggest otherwise I'd to propose that tomorrow's buyers (if such there be) come on board by dint of where we're at on the moving average. Is it not more realistic that investors will buy-in on the back of cittern positive indicators - in turn bringing the moving average with them. Clearly I'm a chart sceptic but will own up to ignorance to go hand-in-hand with my sceptism.
owenmo
19/1/2017
21:26
It seems like this stock is changing to buying on the dips rather than selling the rallies. It feels like the worm has turned.
lodger
19/1/2017
20:19
So we're now sat above the 200 day moving average:



Very bullish if we have a weekly close around or above this level!

parob
19/1/2017
19:56
Risky

Good luck to them there's very little stock about it seems.

Sm

shrewdmole
19/1/2017
19:38
This is an interesting article. So weight may be modified by changing the ambient temperature?
maxwellsdemon
19/1/2017
19:08
Have a feeling opti will start to see some long awaited ii's buying in on the back of recent appointments. Clearly signals transition from development phase which is usually too risky for ii's. £3m still in the bank and revenues on their way what a position to be in..Very surprised to hear sugars potentially available end of year/ early 2018. Serious company in the making.
riskybusiness1
19/1/2017
18:52
I wonder if that Friday only discount is to clear old stock because didn't someone mention they are repackaging the boxes for Go Figure?

Hey....
Wouldn't it be fab if new wording said something about number one diet product?

Mind you, I wonder if it's to print it in different languages the packaging...
Perhaps those worldwide destinations ?

Who knows, time will tell.

joyjoy13
19/1/2017
18:44
No....not selling!
This is my nest egg, biggest investment I've ever had the confidence in because of ALL the strings to their bow!
opportunities worldwide!
But I did my research and continue to watch daily for news so I'm very happy with progress and can't wait for those seminars!
Please do your own research folks, don't be swayed by my opinions.
Good luck

joyjoy13
19/1/2017
18:29
re, 18958, you just might think of selling (some) if it spikes to over £1 one day (on a very good RNS), that will be a good test
neftanikoff
19/1/2017
17:28
Well, I for one wont be selling any, I think the £1 from Zak Mir will be peanuts in the long term!
Look how many divisions they are planing..., the potential is huge!
Just wished I'd of bought more on the dips.

DYOR
good luck all

joyjoy13
19/1/2017
17:23
Sanguine :)
judijudi
19/1/2017
16:56
Hi Elrico, yep I'd confident skinbiotic will be de-risked soon and proved successful. Just need further news and confirmation, but I'm sure its coming... :)
woodaldo
19/1/2017
16:38
"Late stage discussions" way back in October was it not shrewdie? With any IPO there is bound to II participation, so no surprise there, otherwise it would be problematic getting the price OPTI have in mind.
elrico
19/1/2017
16:36
Woodaldo - I would add skinbiotix as derisked also, otherwise why demerge? So, as you rightly point out, 3 divisions have been derisked and I would hope, expect the pending Finncap note would point these facts out.
elrico
19/1/2017
16:34
I'd hazard a guess they are in discussions with early stage investment funds to take a decent stake in the skin subsidiary.
shrewdmole
19/1/2017
16:16
We can't all have missed it, bit surprising not saying anything about it
neftanikoff
19/1/2017
16:13
Woodaldo, agreed and I still believe we will see the anticipated demerger fairly soon.
rafboy
19/1/2017
16:10
I think one of the things to take from that interview is further confirmation that the science works. For such a ground breaking science that this is, it wasn't long ago that we hoped that maybe just 2 of these product lines took off. Now we know the slimbiome works and its market share is going to grow, we know they are launching the cholesterol (optiscreen) product in spring, and now confirmation that sugar (optibiotics) was progressing well and likely to launch at the end of the year. So that's 3 divisions that look like delivering now or in the near future...All very promising.
woodaldo
19/1/2017
16:06
I didn't hear him mention skin demerger. Slimbiome, then cholestrol, then potentially sugar, but no mention of skin this time.
lodger
Chat Pages: Latest  802  801  800  799  798  797  796  795  794  793  792  791  Older

Your Recent History

Delayed Upgrade Clock